K

Active Director Designated Partner DIN 10432238
DIN 10432238 First appointment Dec 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Khadeeja

Data last updated:

Khadeeja is a Designated Partner at Parambil Healthcare Llp (since 2023).

DIN 10432238
Primary Designation Designated Partner
First Appointment 19 Dec 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Dec 20232023Active

Board colleagues of Khadeeja

NameDINCompanyDesignation
Areeb Kodakkat10432237Parambil Healthcare LlpDesignated Partner
Mohammed Ansari Erukulangara10432236Parambil Healthcare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Parambil Healthcare Llp
Premium access

Shareholding and investment profile for Khadeeja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Khadeeja

Khadeeja currently holds 1 directorship: Parambil Healthcare Llp (Designated Partner, since 19 Dec 2023).

Khadeeja was first appointed on 19 Dec 2023 as Designated Partner at Parambil Healthcare Llp.

The current boards of Khadeeja's companies include Areeb Kodakkat (Parambil Healthcare Llp), Mohammed Ansari Erukulangara (Parambil Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available